Global Liver Institute Launches Liver Health Is Public Program
Washington, DC, March 30, 2022 (GLOBE NEWSWIRE) — The Global Liver Institute (GLI), a patient-led, nonprofit liver health organization operating around the world, today announced the launch of its global Liver Health is Public Health (LHPH) initiative with a special program features in the Guardian’s Your Liver 2022 supplement. Liver conditions continue to be misunderstood, mischaracterized, and stigmatized, resulting in underdiagnosis, undertreatment, and unnecessarily poor outcomes. This multi-year program will seek to address these ongoing challenges and change the conversation about liver health.
GLI President and CEO Donna R. Cryer, JD said, “There are half a billion people around the world living with liver disease, including me. Liver disease is stigmatized, underdiagnosed and often untreated, in part because most people lack basic knowledge. It is imperative that people know what steps they can take to prevent liver disease, and health systems must organize themselves to better diagnose and care for liver patients.
It has long been unknown that since everyone has a liver, everyone is at risk or already has some degree of liver disease. With this in mind, over the past few decades, liver disease has become one of the leading causes of death and disease worldwide.
- 2 million deaths per year
- 1 in 4 people are affected by non-alcoholic fatty liver disease (NAFLD). Of these, 1 in 5 people living with NAFLD will develop the most advanced liver disease, non-alcoholic steatohepatitis (NASH).
- 75 million people are at risk of alcohol-associated liver disease (ALD)
- Liver transplantation is the second most common solid organ transplant, yet less than 10% of global transplant needs are met at current rates.
- Viral hepatitis (hepatitis B (HBV) and virus C (HCV)) affects more than 360 million people worldwide
In the USA:
- Cirrhosis affects 633,000 people
- Liver cancer affects 42,000
- HBV affects 2.2 million people
- HCV affects 3.5 million people
- NAFLD affects approximately 76 million
- NASH has an impact of 4.9 million to 19 million
- Alcoholic liver disease (ALD) affects 19 million people.
This initiative will inspire the medical field globally to consider holistic liver health as an integral part of public health, nutrition, activity, prevention, early diagnosis and risk factor management. risk to education, support, optimized clinical pathways and policy for children, adults, and seniors.
Through the development of expert working groups in the intersectional areas of public health, medicine, advocacy, and patient experience, LHPH will evolve the conversation about liver health by:
- Assess the state of liver health around the world
- Develop educational resources for various audiences, and
- Empowering a global cohort of liver health advocates.
If you would like to learn more about LHPH or join a working group to guide the creation of educational materials, please contact Erik Soto at [email protected] in the United States; contact Giacomo Donnini if you are outside the United States at [email protected]
This initiative is made possible in the United States thanks to the support of Salix Pharmaceuticals and, globally, thanks to the support of Sanofi.
About the World Liver Institute
The Global Liver Institute (GLI) is a 501(c)3 nonprofit organization founded on the belief that liver health should take its place on the global public health agenda based on prevalence and impact of liver disease. GLI promotes innovation, encourages collaboration and supports the scale-up of optimal approaches to help eradicate liver disease. Operating globally, GLI is committed to solving the issues that matter to liver patients and equipping advocates to improve the lives of individuals and families affected by liver disease. Follow GLI on Twitter, Facebook, Instagram, LinkedIn and YouTube.